浏览标题索引

标题 文件
卷 8, 编号 1 (2020) MEMBERS OF THE FAMILY LAMIACEAE LINDL. AS SOURCES OF MEDICINAL PLANT RAW MATERIALS TO OBTAIN NEUROTROPIC DRUGS PDF
(Rus)
Zvezdina E., Dayronas Z., Bochkareva I., Zilfikarov I., Babaeva E., Ferubko E., Guseynova Z., Serebryanaya F., Kaibova S., Ibragimov T.
卷 8, 编号 1 (2020) RESULTS OF A COMPARATIVE STUDY OF NIGELLA SATIVA L. SEEDS OILS COMPOSITION PDF
(Rus)
Goryainov S., Khromov A., Bakureza G., Cesar E., Ivlev V., Vorobyev A., Abramovich R., Potanina O., Novikov O.
卷 8, 编号 1 (2020) HPLC METHODS OF FEXOFENADINE QUANTITATIVE ANALYSIS IN RABBITS’ LIVER PDF
(Rus)
Mylnikov P., Chernykh I., Shchulkin A., Popova N., Yakusheva E.
卷 8, 编号 2 (2020) Antitrombotic activity of a new benzimidazole derivative with a spatially difficult phenolic substitute in its structure PDF
(Rus)
PDF
(Eng)
Spasov A., Kucheryavenko A., Gaidukova K., Chernikov M., Zhukovskaya O.
卷 8, 编号 1 (2020) BETAMETHASONE ADMINISTRATION AS A TREATMENT OF CHOICE IN LOCAL POST-TATTOO COMPLICATIONS PDF
(Rus)
Karymov O., Vorobyov A., Kalashnikova S., Polyakova L., Vyskub M.
卷 8, 编号 2 (2020) Complex biostimulation of intrapleural adhesiogenesis in thoracal surgery PDF
(Rus)
PDF
(Eng)
Kalashnikov A., Vorobiev A., Kalashnikova S., Salimov D.
卷 8, 编号 2 (2020) study of antiatherosclerotic and endothelioprotective activity of peptide agonists of EPOR/CD131 heteroreceptor PDF
(Rus)
Puchenkova O., Nadezhdin S., Soldatov V., Zhuchenko M., Korshunova D., Kubekina M., Korshunov E., Korokina L., Golubinskaya P., Kulikov A., Gureev V., Pokrovskiy V., Patrakhanov E., Lebedev P., Denisyuk T., Belyaeva V., Movchan E., Lepetukha E., Pokrovskiy M.
卷 8, 编号 1 (2020) RETROSPECTIVE ANALYSIS OF ADVERSE DRUG REACTION REPORTING FORMS ASSOCIATED WITH PENICILLIN FAMILY ANTIBIOTICS (PCNE-DRP 9.0) BASED ON DRUG-RELATED APPROACH PDF
(Rus)
Matveev A., Krasheninnikov A., Egorova E., Koniaeva E.
卷 8, 编号 2 (2020) Using quantum-chemical parameters for predicting anti-radical (HO∙) activity of related structures containing a cinnamoyl fragment II. derivatives of 2’,4’-dihydroxychalcone, flavanone and flavone, containing a hydroxy group in position 7 PDF
(Rus)
Oganesyan E., Shatokhin S.
卷 8, 编号 1 (2020) PROBLEMS OF PHARMACEUTICAL PROVISION OF POPULATION WITH HYPOLIPIDEMIC DRUGS: THE CASE OF THE VOLGOGRAD REGION (THE RUSSIAN FEDERATION) PDF
(Rus)
Tyurenkov I., Knyazeva J., Ganicheva L., Kaysheva N.
卷 8, 编号 2 (2020) Films in Russian medicine and cosmetology: development history, classification, technology PDF
(Rus)
Kishchenko V., Vernikovsky V., Privalov I., Shevchenko A.
卷 8, 编号 3 (2020) Efficacy and safety of some etiotropic therapeutic schemes for treating patients with novel coronavirus infection (COVID-19) PDF
(Rus)
PDF
(Eng)
Balykova L., Pavelkina V., Shmyreva N., Pyataev N., Selezneva N., Shepeleva O., Almyasheva R.
卷 8, 编号 3 (2020) Clinical-immunological effectiveness of ribomunyl in children with virus-induced bronchial asthma PDF
(Rus)
PDF
(Eng)
Belan E., Nikiforova E., Zayachnikova T., Shishimorov I., Magnitskaya O.
卷 8, 编号 2 (2020) Chemical constituents of Geum rivale L. and their biological activity PDF
(Rus)
Orlova A., Povydysh M.
卷 8, 编号 3 (2020) Additive neuroprotective effect of 3-hydroxypyridine derivatives and human erythropoetin analogue on a hemorrhagic stroke model in rats PDF
(Rus)
PDF
(Eng)
Kolesnichenko P., Shcheblykina O., Nesterova N., Shcheblykin D., Nesterov A., Pokrovsky M., Zhuchenko M., Tverskoy A., Reznikov K.
卷 8, 编号 3 (2020) Antibacterial and immunotropic properties of isoliquiritigenin in generalized staphylococcal infection in mice PDF
(Rus)
PDF
(Eng)
Solyonova E., Pavlova S.
卷 8, 编号 4 (2020) Pharmacodynamics of oral anticoagulants in patients with atrial fibrillation in the acute period of ischemic stroke PDF
(Rus)
PDF
(Eng)
Petrov V., Gerasimenko A., Gorbatenko V., Shatalova O.
卷 8, 编号 3 (2020) Conceptually-theoretical justification and updating of the preventive approach in the implementation of a pharmacist’s information consultancy services in the public health system PDF
(Rus)
PDF
(Eng)
Kirshchina I., Soloninina A., Mikhailova V.
卷 8, 编号 4 (2020) Development of a solid dosage form with adsorption activity PDF
(Rus)
PDF
(Eng)
Chirkova M., Gulyaev D., Chugunova M., Belonogova V.
卷 8, 编号 4 (2020) Study of the stability of the substance 3-[2-(4-phenyl-1- piperazino)-2-oxoethyl]quinazoline-4(3н)-one under stressful conditions PDF
(Eng)
PDF
(Rus)
Gendugov T., Glushko A., Ozerov A., Shcherbakova L.
卷 8, 编号 3 (2020) Comparative analysis of Lebanon development. Prospects for cooperation with the Russian Federation PDF
(Rus)
PDF
(Eng)
El Moussawi M., Mironenkova Z., Umarov S., Knysh O., Nemyatykh O.
卷 8, 编号 4 (2020) Estimation of the efficiency of hormone-regulating synchronization of ovulation in female mice PDF
(Rus)
PDF
(Eng)
Pokrovsky V., Patrakhanov E., Lebedev P., Belashova A., Karagodina A., Shabalin A., Nesterov A., Markovskaya V., Pokrovsky M.
卷 8, 编号 5 (2020) Mumps: achievements, problems and ways of solution PDF
(Rus)
PDF
(Eng)
Semerikov V., Yuminova N., Postanogova N., Sofronova L.
卷 8, 编号 4 (2020) The search for neuroprotective compounds among new ethylthiadiazole derivatives PDF
(Eng)
PDF
(Rus)
Cherevatenko R., Antsiferov O., Skachilova S., Pokrovsky M., Gureev V., Banchuk I., Banchuk A., Golubinskaya M., Syromyatnikova A., Rozhkov I., Mostovykh A.
卷 8, 编号 5 (2020) Correction of morphofunctional disorders in experimental preeclampsy by combined use of trimetazidine and purified micronized flavonoid fraction as well as their combinations with methylampsy PDF
(Eng)
PDF
(Rus)
Antsiferova O., Teleschenko M., Tsuverkalova Y., Pokrovsky M., Gureev V., Zatolokina M., Gureeva A.
卷 8, 编号 5 (2020) Сomparative analysis of drug efficacy in the treatment for COVID-19 severe forms, based on attribute-based statistic methods and analysis of drug interactions PDF
(Rus)
PDF
(Eng)
Zhukova O., Kagramanyan I., Khokhlov A.
卷 8, 编号 4 (2020) Analysis of the implementation of the federal assurance program of supporting beneficiaries with indispensable medicinal preparations in the subjects of the Russian Federation PDF
(Rus)
PDF
(Eng)
Petrukhina I., Yagudina R., Ryazanova T., Kurkin V., Pervushkin S., Egorova A., Loginova L., Khusainova A., Blinkova P.
卷 8, 编号 5 (2020) Effect of the GABA derivative succicard on the lipid and carbohydrate metabolism in the offspring of rats with experimental preeclampsia in early and late ontogeny PDF
(Eng)
PDF
(Rus)
Muzyko E., Perfilova V., Nesterova A., Suvorin K., Tyurenkov I.
卷 8, 编号 5 (2020) Comparative review of methodologies for estimating the cost of adverse drug reactions in the Russian Federation and Brazil PDF
(Rus)
PDF
(Eng)
Syraeva G., Kolbin A., Matveev A., Panezhina V.
卷 8, 编号 6 (2020) Mechanisms of cytokine storm development in COVID-19 and new potential targets of pharmacotherapy PDF
(Rus)
PDF
(Eng)
Petrov V., Amosov A., Gerasimenko A., Shatalova O., Ponomareva A., Akinchits A., Kulakova I., Gorbatenko V.
卷 8, 编号 5 (2020) Hemorheological properties of the 5-HT2a-antagonist of the 2-methoxyphenyl-imidazobenzimidazole derivative of the RU-31 compound and cyproheptadine, in comparison with penthoxyphylline PDF
(Eng)
PDF
(Rus)
Yakovlev D., Naumenko L., Sultanova K., Spasov A.
卷 8, 编号 6 (2020) Pharmacogenetic bases of individual sensitivity and personalized administration of antiplatelet therapy in different ethnic groups PDF
(Rus)
PDF
(Eng)
Kantemirova B., Orlova E., Polunina O., Chernysheva E., Abdullaev M., Sychev D.
卷 8, 编号 5 (2020) Problems of responsible self-medication of allergy symptoms and farmaceutical counseling PDF
(Rus)
PDF
(Eng)
Izrafilova V., Egorova S., Garifullina G., Akhmetova T.
卷 8, 编号 6 (2020) Phleboprotectors based on flavonoids: dosage forms, biopharmaceutical characteristics, technological features PDF
(Rus)
PDF
(Eng)
Stepanova E., Remezova I., Shevchenko A., Morozov A., Maltseva V.
卷 8, 编号 5 (2020) Analysis of industrial practice of drug quality risk management in russian pharmaceutical enterprises PDF
(Rus)
PDF
(Eng)
Kashirina A., Aladysheva Z., Pyatigorskaya N., Belyaev V., Beregovyh V.
卷 8, 编号 6 (2020) Application of multipotent mesenchymal stem cell secretome in the treatment of adjuvant arthritis and contact-allergic dermatitis in animal models PDF
(Rus)
PDF
(Eng)
Golubinskaya P., Sarycheva M., Dolzhikov A., Bondarev V., Stefanova M., Soldatov V., Nadezhdin S., Korokin M., Pokrovsky M., Burda Y.
卷 8, 编号 6 (2020) Correction of psychoneurological signs of acute alcohol intoxication in rats with a new acetylcysteine-based composition PDF
(Rus)
PDF
(Eng)
Kurkin D., Morkovin E., Osadchenko N., Bakulin D., Abrosimova E., Dubrovina M., Kovalev N., Gorbunova Y., Tyurenkov I.
卷 9, 编号 1 (2021) Dendrimers in anticancer targeted drug delivery: accomplishments, challenges and directions for future PDF
(Rus)
PDF
(Eng)
Amjad M.
卷 9, 编号 1 (2021) Biological activity of Hypericum perforatum L. (Hypericaceae): a review PDF
(Rus)
PDF
(Eng)
Budantsev A., Prikhodko V., Varganova I., Okovityi S.
卷 8, 编号 6 (2020) Pharmacoeconomic evaluation of anti-pneumococcal vaccination in risk groups for the prevention of community-acquired pneumonia among adults in the Astrakhan region PDF
(Rus)
PDF
(Eng)
Orlova E., Dorfman I., Orlov M., Abdullaev M.
卷 9, 编号 1 (2021) Pharmaceutical services: status and development trends PDF
(Rus)
PDF
(Eng)
Klimenkova A., Geller L., Skripko A., Gravchenko L., Korzhavykh E.
卷 8, 编号 6 (2020) Use of quantum-chemical parameters for forecasting antiradical (HO·) activity of related structures containing a cinnamic mold fragment. III. Chalcones, flavanones and flavones with phloroglucinic type of ring “A” PDF
(Rus)
PDF
(Eng)
Oganesyan E., Shatokhin S.
卷 9, 编号 1 (2021) Approaches to the selection of excipients for dental gel with cetylpyridinium chloride PDF
(Rus)
PDF
(Eng)
Zagorulko E., Karavaeva A.
卷 8, 编号 6 (2020) Study of pharmaceutical specialists’ information awareness on the matters of drug abuse PDF
(Rus)
PDF
(Eng)
Porseva N., Soloninina A., Dvorskaya O.
卷 9, 编号 1 (2021) Multisensory colorimetric analysis of drugs dydrogesterone, troxerutin and ademetionine using barcodes PDF
(Rus)
PDF
(Eng)
Monogarova O., Chaplenko A., Oskolok K.
卷 9, 编号 1 (2021) Study of the safety of antianemic preparations by method of the system of problems related to medicinal preparations PDF
(Rus)
PDF
(Eng)
Matveev A., Egorova E., Koniaeva E., Bekirova E., Adzhimamutova L.
卷 8, 编号 6 (2020) Life quality assessment of patients with stable coronary artery disease after myocardial revascularization PDF
(Rus)
PDF
(Eng)
Narkevich I., Nemyatykh O., Kovaleva K., Ratova L., Trushnikova I., Parizhskaya E., Konradi A.
卷 9, 编号 1 (2021) Molecular design of N-acyl derivatives of 2-(2-oxopyrolidin-1-yl)-acetamide with GABA-ergic and glutamatergic activities PDF
(Rus)
PDF
(Eng)
Kodonidi I., Chiriapkin A., Tworowski D.
卷 8, 编号 6 (2020) Number of runs variations on Autodock 4 do not have a significant effect on RMSD from docking results PDF
(Rus)
PDF
(Eng)
Pratama M., Siswandono S.
卷 9, 编号 3 (2021) Genetic predictors of severity and efficacy of COVID-19 pharmacotherapy PDF
(Rus)
PDF
(Eng)
Shishimorov I., Magnitskaya O., Ponomareva Y.
卷 9, 编号 1 (2021) Obituary for Yuri N. Chernov. 5 nov 1937 – 1 jan 2021 PDF
(Rus)
PDF
(Eng)
Vasin M., Esaulenko I., Kukes V., Petrov V., Ushakov I., Khokhlov A.
卷 9, 编号 3 (2021) Standardization problems of medicinal preparations from Rhodiola rosea L. PDF
(Rus)
PDF
(Eng)
Kurkin V., Ryazanova T.
卷 9, 编号 3 (2021) Effect of solid dispersions on the solubility of metronidazole PDF
(Rus)
PDF
(Eng)
Krasnyuk I., Naryshkin S., Krasnyuk I., Belyatskaya A., Stepanova O., Bobrov I., Yankova V., Rau J., Vorobiev A.
卷 9, 编号 3 (2021) Experimental study of toxic properties of VMU-2012-05 drug – original non-nucleeside inhibitor of HIV-1 reverse transcriptase PDF
(Rus)
PDF
(Eng)
Vavilova V., Shekunova E., Jain E., Balabanyan V., Ozerov A., Makarova M., Makarov V.
卷 9, 编号 3 (2021) Synthesis, antiaggregation and antitrombotic activities of new derivatives of hydroxybenzoic acids with tauric fragment PDF
(Rus)
PDF
(Eng)
Brel A., Atapina N., Budaeva Y., Lisina S., Tsaruk S., Kurkin D., Tyurenkov I.
卷 9, 编号 3 (2021) Economic aspects of application of the russian biosimilar omalizumab in patients with atopic bronchial asthma of moderate to severe clinical courses PDF
(Rus)
PDF
(Eng)
Krysanova V., Ermolaeva A., Ermolaeva T., Davydovskaya M., Kokushkin K.
卷 9, 编号 4 (2021) Antitumor drugs based on indolocarbazol derivatives PDF
(Rus)
PDF
(Eng)
Kolpaksidi A., Dmitrieva M., Yarosh I., Krasnyuk I.
卷 9, 编号 4 (2021) Development and validation of methods for quantitative determination of active pharmaceutical substances in nasal spray PDF
(Rus)
PDF
(Eng)
Larskiy M., Pozdnyakova A., Khadzhieva Z., Pozdnyakov D.
卷 9, 编号 4 (2021) Effect of cryopreserved placenta extract on some biochemical indices of therapeutic efficiency and toxicity of diclofenac sodium in adjuvant-induced experimental arthritis PDF
(Rus)
PDF
(Eng)
Hladkykh F., Chyzh M., Manchenko A., Belochkina I., Mikhailova I.
卷 9, 编号 4 (2021) Study of the pharmacological activity of novel EPOR/CD131 heteroreceptor agonists in mice with endothelial-specific expression of mutant Polg gene PDF
(Rus)
PDF
(Eng)
Korokin M., Kubekina M., Deykin A., Antsiferov O., Pokrovskii V., Korokina L., Kartashkina N., Soldatova V., Kuzubova E., Radchenko A., Pokrovskii M.
卷 9, 编号 4 (2021) Influence of certain d-metals on formation of advanced glycation end products, aggregation and amyloid transformation of albumin in glycation reaction PDF
(Rus)
PDF
(Eng)
Litvinov R., Gontareva A., Usmiyanova L., Klimenko D.
卷 9, 编号 4 (2021) Antimicrobial activity study of new quinazolin-4(3h)-ones against Staphylococcus aureus and Streptococcus pneumoniae PDF
(Rus)
PDF
(Eng)
Samotrueva M., Ozerov A., Starikova A., Gabitova N., Merezhkina D., Tsibizova A., Tyurenkov I.
卷 9, 编号 5 (2021) PLGA – the smart polymer for drug delivery PDF
(Rus)
PDF
(Eng)
Surya N., Bhattacharyya S.
卷 9, 编号 5 (2021) Heat shock protein Hsp70: prerequisites for use as a medicinal product PDF
(Rus)
PDF
(Eng)
Pokrovsky V., Patrakhanov E., Antsiferov O., Kolesnik I., Belashova A., Soldatova V., Pokopeiko O., Karagodina A., Arkhipov I., Voronina D., Sushkova D.
卷 9, 编号 5 (2021) Methods for quantitative determination of total flavonoids in Quercus robur L. buds PDF
(Rus)
PDF
(Eng)
Ryabov N., Ryzhov V., Kurkin V.
卷 9, 编号 5 (2021) Synthesis and antioxidant activity of (E)-3-(3-(4-oxo-4H-chromen-3-yl)acryloyl) 2H-chromen-2-one derivatives PDF
(Rus)
PDF
(Eng)
Shatokhin S., Tuskaev V., Gagieva S., Pozdnyakov D., Oganesyan E.
卷 9, 编号 6 (2021) A few representatives of Asteroidae (Asteraceae) subfamily and Geranium (Geraniaceae) genus in the Baikal region (review) PDF
(Rus)
PDF
(Eng)
Privalova E.
卷 9, 编号 5 (2021) Type 2 diabetes mellitus’s decompensated form: on the problem of effective pharmacotherapy in real clinical practice PDF
(Rus)
PDF
(Eng)
Safronenko A., Gantsgorn E., Sanina E., Khachumova M., Panenko S., Kuznetsov I., Kivva A., Polyakova V.
卷 9, 编号 6 (2021) Development of peroral hypolipidemic formulation based on sulfated arabinogalactan in the form of potassium salt PDF
(Rus)
PDF
(Eng)
Kostyro Y., Alekseev K.
卷 9, 编号 5 (2021) Cost-minimization analysis of using short and long-acting erythropoesis-stimulating agents for correction of nephrogenic anemia against the background of substitution therapy PDF
(Rus)
PDF
(Eng)
Krysanov I., Ermakova V., Vaskova L., Tiapkina M.
卷 9, 编号 6 (2021) Study of clinical and pathogenetic effects of anti-viral drug based on favipiravir in comorbid patients with COVID-19 at the outpatient stage of treatment PDF
(Rus)
PDF
(Eng)
Balykova L., Radaeva O., Zaslavskaya K., Kostina Y., Iskandyarova M., Negodnova E., Eremeev V., Sabirov L., Semeleva E.
卷 9, 编号 6 (2021) Clinical and economic justification of software screening performance of colorectal cancer at the region level PDF
(Rus)
PDF
(Eng)
Petukhova Y., Eliseeva E., Petukhova A.
卷 9, 编号 5 (2021) Antihistamines: research and analysis of the regional retail market PDF
(Rus)
PDF
(Eng)
Prokopenko V., Kabakova T., Chernikov M., Goryachev A., Mikhailova S., Knysh O.
卷 9, 编号 6 (2021) Antitumor activity in vivo of aqueous and alcoholic extracts of Thymus Marschallianus Willd PDF
(Rus)
PDF
(Eng)
Sheremetyeva A., Napsheva A., Durnova N.
卷 10, 编号 1 (2022) Current state of research in the field of chemical composition and pharmacological effects of zea maydis styli cum stigmatis PDF
(Rus)
PDF
(Eng)
Nikiforova E., Bat N., Davitavyan N.
卷 9, 编号 5 (2021) Actual problems of professional and personal development of qualified persons responsible for quality of medicinal products for human use PDF
(Rus)
PDF
(Eng)
Aladysheva Z., Pyatigorskaya N., Belyaev V., Nikolenko N., Nesterkina E., Loseva S.
卷 9, 编号 6 (2021) Effect of glyprolines on the level of apoptotic and neurotrophic factors under conditions of “social” stress PDF
(Rus)
PDF
(Eng)
Yasenyavskaya A., Tsibizova A., Andreeva L., Myasoedov N., Bashkina O., Samotrueva M.
卷 10, 编号 1 (2022) Obesity as a reflection of psycho-emotional disorders: focus on pharmacotherapy PDF
(Rus)
PDF
(Eng)
Shishkova V.
卷 10, 编号 1 (2022) Features of quantitative estimation of flavonoid content in juglans nigra l. barks preparations PDF
(Rus)
PDF
(Eng)
Kurkin V., Zimenkina N.
卷 9, 编号 6 (2021) Analysis of the personnel’s consistent readiness for changes as illustrated by the example of an export-oriented biotechnological enterprise PDF
(Rus)
PDF
(Eng)
Kazakova E., Trukhin V., Narkevich I., Basakina I.
卷 10, 编号 1 (2022) Study of organic acids profile of genus Persicaria Mill species PDF
(Rus)
PDF
(Eng)
Chistyakova A., Gudkova A., Slivkin A., Chupandina E.
卷 9, 编号 6 (2021) Use of sequencing methods for species identification exemplified by phylogenetic relationships within genus Hedysarum L. PDF
(Rus)
PDF
(Eng)
Imachueva J., Serebryanaya F., Machs E., Kotseruba V.
卷 10, 编号 1 (2022) Development of nitrofuran derivative: composition and technology of effervescent tablets with solid dispersions PDF
(Rus)
PDF
(Eng)
Elagina A., Belyatskaya A., Krasnyuk I., Krasnyuk I., Stepanova O., Fateeva T., Smolyarchuk E., Kozin S., Plakhotnaya O., Rastopchina O., Rau J.
卷 10, 编号 1 (2022) Application of multivariate anova and generalized desirability to optimize the composition and technology of tablets containing N-benzyl-N-methyl-1-phenylpyrrolo [1,2-a] pyrazine-3-carboxamide PDF
(Rus)
PDF
(Eng)
Tishkov S., Blynskaya E., Alekseev K., Alekseev V., Gavrilov D.
卷 10, 编号 1 (2022) Pharmacological activity of extracts from plants of cosmos bipinnatus cav. species PDF
(Rus)
PDF
(Eng)
Kulichenko E., Andreeva O., Sergeeva E., Sigareva S., Terekhov A., Oganesyan E., Sidorskaya S.
卷 10, 编号 3 (2022) Cluster analysis of integrated “drug supply” concept PDF
(Rus)
PDF
(Eng)
Barkaev G., Kabakova T., Goryachev A.
卷 10, 编号 3 (2022) Phytochemical and microbiological aspects of the Nigella sativa l. herbs study PDF
(Rus)
PDF
(Eng)
Mubinov A., Kurkin V., Avdeeva E., Kolpakova S., Zhestkov A.
卷 10, 编号 1 (2022) Pharmacotherapy possibilities of cardiovascular autonomous neuropathy in children with type 1 diabetes mellitus at the preclinical stage PDF
(Rus)
PDF
(Eng)
Malyuzhinskaya N., Shishimorov I., Magnitskaya O., Stepanenko K., Polyakova O., Klitochenko G., Petrova I., Emelyanova S., Skiba A.
卷 10, 编号 3 (2022) Optimization technology of fat-soluble vitamins production based on alkaline hydrolysis PDF
(Rus)
PDF
(Eng)
Sysuev E., Stepanova E., Noskova V.
卷 10, 编号 3 (2022) Polypharmacy in managment of in-patients with novel coronavirus disease (COVID-19) PDF
(Rus)
PDF
(Eng)
Petrov V., Ryazanova A., Privaltseva N., Nekrasov D.
卷 10, 编号 1 (2022) Evaluation of ABCB1-protein inhibition prospectiveness in hematoencephalic barrier as method for increasing efficiency of pharmacotherapy in cerebral ischemia PDF
(Rus)
PDF
(Eng)
Chernykh I., Shchulkin A., Gatsanoga M., Yakusheva E.
卷 10, 编号 3 (2022) Clinical and economic evaluation of atezolizumab + vemurafenib + cobimetinib combination and nivolumab + ipilimumab combination: administration in metastatic melanoma treatment with BRAF-confirmed mutation in adult patients PDF
(Rus)
PDF
(Eng)
Krysanov I., Makarova E., Ermakova V.
卷 10, 编号 1 (2022) Effectiveness and safety of favipiravir infusion in patients hospitalized with COVID-19 PDF
(Rus)
PDF
(Eng)
Balykova L., Zaslavskaya K., Pavelkina V., Pyataev N., Selezneva N., Kirichenko N., Ivanova A., Rodoman G., Kolontarev K., Skrupsky K., Simakina E., Mubarakshina O., Taganov A., Pushkar D.
卷 10, 编号 3 (2022) Evaluation of weight reduction efficacy and safety of sibutramin-containing drugs in patients with alimentary obesity PDF
(Rus)
PDF
(Eng)
Demidova T., Izmailova M., Ushakova S., Zaslavskaya K., Odegova A., Popova V., Nevretdinova M., Verbovoy A., Bely P.
卷 10, 编号 2 (2022) Activity modulation of various nitric oxide syntases as an approach to endothelial dysfunction therapy PDF
(Rus)
PDF
(Eng)
Kurkin D., Abrosimova E., Bakulin D., Kovalev N., Dubrovina M., Borisov A., Strygin A., Morkovin E., Tyurenkov I.
卷 10, 编号 2 (2022) Minimisation of risks associated with the use of pollen-based medicines, at the stage of pollen collection PDF
(Rus)
PDF
(Eng)
Taube A., Buyanova T., Sakanyan E.
卷 10, 编号 2 (2022) Comparative pharmacoeconomic analysis of long-acting lanreotide used in acromegaly therapy within conditions of the Russian Federation health care system PDF
(Rus)
PDF
(Eng)
Krysanov I., Makarova E., Ermakova V.
卷 10, 编号 2 (2022) Gender characteristics of adverse drug reactions development: experience of regional database analysis PDF
(Rus)
PDF
(Eng)
Matveev A., Krasheninnikov A., Egorova E., Konyaeva E., Matveeva N.
卷 10, 编号 2 (2022) Economic damage of pneumococcal vaccination absence as a risk factor for complications of chronic obstructive pulmonary disease PDF
(Rus)
PDF
(Eng)
Orlova E., Dorfman I., Umerova A., Kantemirova B., Orlov M., Abdullaev M.
卷 10, 编号 2 (2022) Clinical and economic analysis of genetically engineered biologics consumption by patients with COVID-19 PDF
(Rus)
PDF
(Eng)
Petrov V., Ryazanova A., Ponomareva A., Shatalova O., Levina Y.
卷 10, 编号 2 (2022) Evaluation of antioxidant activity level of Actinidia arguta (Siebold et Zucc.) Planch. ex Miq. Plant raw material, grown in the caucasian mineral waters region PDF
(Rus)
PDF
(Eng)
Pozdnyakov D., Adzhiakhmetova S., Vdovenko-Martynova N.
卷 10, 编号 2 (2022) Study of long-term clinical and pathogenetic effects of favipiravir-based anti-viral drug in patients with metabolic syndrome in post-COVID period PDF
(Rus)
PDF
(Eng)
Radaeva O., Balykova L., Zaslavskaya K., Taganov A., Bely P., Kostina Y., Negodnova E., Mashnina S., Bessheinov D., Iskandyarova M., Eremeev V., Chumakov N.
卷 10, 编号 4 (2022) Evaluation of plant-based UV filters potential in modern concept view of skin photoprotection PDF
(Rus)
PDF
(Eng)
Nemyatykh O., Terninko I., Sabitov A., Lyashko A., Sakipova Z.
卷 10, 编号 4 (2022) Development of microcapsules based on combined antidiabetic substance: pharmacological characteristics PDF
(Rus)
PDF
(Eng)
Giyoszoda A., Stepanova E., Veselova O., Storozhenko S.
卷 10, 编号 4 (2022) Adaptation of “dried blood drop” method for therapeutic drug monitoring PDF
(Rus)
PDF
(Eng)
Petrov V., Anikeev I., Zayachnikova T., Strygin A., Dotsenko A.
卷 10, 编号 4 (2022) Interrelation between mitochondrial enzyme activity and antioxidant activity of secondary polyphenol nature metabolites in hemiparasite Viscum album L. leaves PDF
(Rus)
PDF
(Eng)
Adzhiakhmetova S., Pozdnyakov D., Chervonnaya N., Kulichenko E., Oganesyan E.
卷 10, 编号 4 (2022) Safety study of romiplostim biosimilar PDF
(Rus)
PDF
(Eng)
Afanasyeva A., Saparova V., Karal-Ogly J., Mukhametzyanova E., Kurkin D., Kalatanova A., Makarenko I., Khokhlov A., Lugovik I.
卷 10, 编号 4 (2022) Modern directed antiviral COVID-19 therapy: results of multicenter clinical effectiveness and safety study of fixed nirmatrelvir+ritonavir combination PDF
(Rus)
PDF
(Eng)
Balykova L., Selezneva N., Gorshenina E., Shepeleva O., Kirichenko N., Simakina E., Kolontarev K., Pushkar D., Zemskov D., Zaslavskaya K., Noskov S., Taganov A., Bely P.
卷 10, 编号 4 (2022) Synergic effect of preparation with coordination complex “trimethydrazinium propionate+ethymth methylhydroxypiridine succinate” on energy metabolism and cell respiration PDF
(Rus)
PDF
(Eng)
Zhuravleva M., Granovskaya M., Zaslavskaya K., Kazaishvili Y., Scherbakova V., Andreev-Andrievskiy A., Pozdnyakov D., Vyssokikh M.
卷 10, 编号 6 (2022) Molecular mechanisms underlying therapeutic action of vitamin B6 PDF
(Rus)
PDF
(Eng)
Zagubnaya O., Nartsissov Y.
卷 10, 编号 6 (2022) Development of murine stem cells with conditional knockout of humanized Snca gene PDF
(Rus)
PDF
(Eng)
Patrakhanov E., Pokrovsky V., Karagodina A., Krayushkina A., Zhunusov N., Deykin A., Korokin M., Pokrovsky M., Altukhova О.
卷 10, 编号 6 (2022) Hypoglycemic effect of sitagliptin and aminoguanidine combination in experimental diabetes mellitus PDF
(Rus)
PDF
(Eng)
Kurkin D., Bakulin D., Morkovin E., Gorbunova Y., Strygin A., Andriashvili T., Sokolova A., Bolokhov N., Pustynnikov V., Fomichev E.
卷 10, 编号 6 (2022) DF-5 compound delays development of diabetic nephropathy in rats PDF
(Rus)
PDF
(Eng)
Spasov A., Zhukovskaya O., Rashchenko A., Brigadirova A., Litvinov R., Gurova N., Smirnov A., Pan’shin N., Abbas H., Morkovnik A.
卷 10, 编号 6 (2022) Bioequivalence study of generic molnupiravir in healthy volunteers PDF
(Rus)
PDF
(Eng)
Vasilyuk V., Boroduleva A., Sobolev P., Nikiforova A., Mozgovaya V., Filon O., Zinkovskaya A., Ignatiev V., Samsonov M., Kozlova I., Khanonina E.
卷 10, 编号 6 (2022) Efficacy and safety of original drug based on hexapeptide succinate in complex COVID-19 therapy in adults hospitalized patients PDF
(Rus)
PDF
(Eng)
Balykova L., Radaeva O., Zaslavskaya K., Bely P., Pavelkina V., Pyataev N., Ivanova A., Rodoman G., Kostina N., Filimonov V., Simakina E., Bystritsky D., Agafyina A., Koryanova K., Pushkar D.
卷 10, 编号 6 (2022) Experimental participation of pharmacological substances in mechanisms of lead acetate toxicity PDF
(Rus)
PDF
(Eng)
Dzugkoev S., Dzugkoeva F., Margieva O., Khubulova A., Mozhaeva I.
卷 10, 编号 5 (2022) Molecular mechanisms defining application of glycine and zinc combination in correction of stress and anxiety main manifestations PDF
(Rus)
PDF
(Eng)
Shishkova V., Nartcissov Y., Titova V., Sheshegova E.
卷 10, 编号 5 (2022) Conventional approaches to the therapy of hereditary myopathies PDF
(Rus)
PDF
(Eng)
Pokrovsky M., Korokin M., Krayushkina A., Zhunusov N., Lapin K., Soldatova M., Kuzmin E., Gudyrev O., Kochkarova I., Deikin A.
卷 10, 编号 5 (2022) Current aspects of etiotropic COVID-19 therapy PDF
(Rus)
PDF
(Eng)
Zemskov D., Balykova L., Radaeva O., Zaslavskaya K., Bely P., Semenova E., Shirmankina M., Koryanova K.
卷 10, 编号 5 (2022) Consumption details of systemically acting antiviral and antimicrobial preparations in period of novel coronavirus infection spread in retail sector of Samara region pharmaceutical market PDF
(Rus)
PDF
(Eng)
Petrukhina I., Lebedev P., Sirotko I., Ryazanova T., Gladunova E., Garanin A.
卷 10, 编号 5 (2022) Characteristics of olokizumab pharmacokinetics in patients with novel coronavirus infection COVID-19 PDF
(Rus)
PDF
(Eng)
Tavlueva E., Zernova E., Kutepova M., Kostina N., Lesina V., Mould D., Ito K., Zinchenko A., Dolgorukova A., Nikolskaya M., Lemak M., Filon O., Samsonov M.
卷 10, 编号 5 (2022) Hemostimulating properties of the conjugates of granulocyte-macrophage colony stimulating factor with alendronic acid PDF
(Rus)
PDF
(Eng)
Shimina G., Bateneva A., Tsyplenkova E., Gamaley S., Esina T., Volosnikova E., Danilenko E.
卷 10, 编号 5 (2022) В6.А-Dysfprmd/GeneJ mice as a genetic model of dysferlinopathy PDF
(Rus)
PDF
(Eng)
Korokin M., Kuzubova E., Radchenko A., Deev R., Yakovlev I., Deikin A., Zhunusov N., Krayushkina A., Pokrovsky V., Puchenkova O., Chaprov K., Ekimova N., Bardakov S., Chernova O., Emelin A., Limaev I.
卷 5, 编号 1 (2017) “Antidotarium ” of Nicholas of Salerno : the history of the pharmacopoeia PDF
(Rus)
Voronov F., Ruzhinskaya I.
卷 7, 编号 6 (2019) 11-amino acid peptide imitating the structure of erythropoietin α-helix b improves endothelial function, but stimulates thrombosis in rats. PDF
(Rus)
Korokin M., Soldatov V., Tietze A., Golubev M., Belykh A., Kubekina M., Puchenkova O., Denisyuk T., Gureyev V., Pokrovskaya T., Gudyrev O., Zhuchenko M., Zatolokina M., Pokrovskiy M.
卷 1, 编号 1 (2013) ABSTRACTS PDF
(Rus)
- -.
卷 3, 编号 5s (2015) AT1-BLOCKING ACTIVITY IN THE VARIETY OF BIPHENYL-BEARING BENZIMIDAZOLE PDF
(Rus)
Spasov A., Brigadirova A., Yakovlev D.
卷 4, 编号 6 (2016) AMINOACID COMPOSITION OF SOME SPECIES FROM INULA GENUS PDF
(Rus)
Kruglaya A.
卷 10, 编号 4 (2022) Corrigendum: “Evaluation of weight reduction efficacy and safety of sibutramin-containing drugs in patients with alimentary obesity” PDF
(Rus)
PDF
(Eng)
Demidova T., Izmailova M., Ushakova S., Zaslavskaya K., Odegova A., Popova V., Nevretdinova M., Verbovoy A., Bely P.
卷 7, 编号 1 (2019) STIMULATION OF REPARATION IN A LINEAR WOUND MODEL IN RATS BY BISCHOFIT GEL PDF
(Rus)
Stepenko Y., Soldatov V., Zatolokina M., Mayorova A., Sysuev B., Demidenko A., Ivahno E., Sarycheva M., Pokrovskiy M.
卷 2, 编号 6 (2014) PHENOLIC COMPOUNDS OF WATER-ETHANOLIC EXTRACT OF MENTHA LONGIFOLIA L PDF
(Rus)
Grebennikova О., Paliy А., Rabotyagov V.
卷 3, 编号 5s (2015) 5-HT1A AGONIST OF BUSPIRONE RECEPTORS NORMALIZES THE CONSEQUENCE OF NEONATAL HYPOXIA IN ADULT RATS PDF
(Rus)
Mikhaylenko V., Butkevich I.
卷 6, 编号 6 (2018) THE AGGREGATE APPROACH TO THE PERIODIZATION OF THE FORMATION OF THE PHARMACOVIGILANCE SYSTEM PDF
(Rus)
Krasheninnikov A.
卷 2, 编号 2 (2014) ADAPTING OF THE MILITARY PHARMACEUTISTS TO LABOUR ACTIVITY PDF
(Rus)
Khomutetskaya N., Golub A.
卷 4, 编号 6 (2016) ADMINISTRATIVE AND ORGANIZATIONAL ASPECTS OF FUNCTIONING OF THE SYSTEM OF AVAILABILITY NARCOTIC AND PSYCHOTROPIC MEDICINAL PREPARATIONS FOR PATIENTS WHO NEED THEM PDF
(Rus)
Kaminskaya I., Tyurenkov I.
卷 6, 编号 2 (2018) ACTUAL PROBLEMS OF RAW MATERIALS CHEMICAL STANDARDIZATION OF MEDICINAL PLANTS OF THE GENUS HAWTHORN ΈCRATAEGUS L.Ή PDF
(Rus)
Morozova T., Kurkin V., Pravdivtseva O.
卷 3, 编号 4 (2015) ANALYSIS OF ANTIDIABETIC DRUGS ASSORTMENT REPRESENTED ON THE PHARMACEUTICAL MARKET OF SAINT PETERSBURG PDF
(Rus)
Miroshnichenko Y., Vasyagina Y., Scherba M.
卷 3, 编号 6 (2015) THE ANALYSIS OF THE RANGE OF ANTI-DECUBITUS PRODUCTS PDF
(Rus)
Tanduyeva D., Pagiyeva E.
卷 6, 编号 6 (2018) ANALYSIS OF ADVERSE DRUG REACTION REPORT FORMS ON THE MEDICINES, USED FOR AIDS TREATMENT (REGISTERED IN THE REPUBLIC OF CRIMEA IN THE PERIOD FROM 2011 TO 2016) PDF
(Rus)
Matveev A., Krasheninnikov A., Egorova E., Konyaeva E.
卷 3, 编号 5s (2015) ANALYSIS OF A PATHOMORPHOSIS OF ALIMENTARY DEFICIT OF MAGNESIUM IN UTERUS AND OVARY WITH DIFFERENT SALTS OF MAGNESIUM PDF
(Rus)
Tolokolnikov V., Spasov A., Smirnov A., Bugayova L., Lebedeva S.
卷 3, 编号 4 (2015) ANALYSIS OF PHARMACEUTICAL SUPPORRT OF ONCOLOGICAL PATIENTS WITH NARCOTIC ANALGESICS IN THE OUTPATIENT SETTING IN NIZHNI NOVGOROD PDF
(Rus)
Kononova S., Lebedeva M.
卷 3, 编号 6 (2015) THE ANALYSIS OF MEASUREMENTS FOR SMALL AND MEDIUM BUSINESSES SUPPORT PDF
(Rus)
Tabolova E., Gatagonova M.
卷 3, 编号 1 (2015) ANALYSIS OF DRUGS ASSORTMENT APPLIED FOR REHABILITATION TREATMENT IN NEUROLOGY DEPARTMENT OF HEALTH RESORT FOR PATIENTS INJURED IN EMERGENCY SITUATIONS PDF
(Rus)
Kabakova T., Zarbolganova A.
卷 4, 编号 2 (2016) ANALYSIS POLYVINYLPYRROLIDONE IN DOSAGE FORMS PDF
(Rus)
Nikolaeva L., Gulyakin I., Oborotova N., Bunyatyan N.
卷 3, 编号 6 (2015) THE ANALYSIS OF CONSUMER PREFERENCES FOR SPORT NUTRITION PRODUCTS IN THE REPUBLIC OF NORTH OSSETIA - ALANIA PDF
(Rus)
Badalyan Z.
卷 3, 编号 5 (2015) ANALYSIS OF LEGAL ASPECTS OF STORAGE OF MEDICAL PRODUCTS APPOINTED FOR MEDICAL AND SANITARY CONSEQUENCESOF EMERGENCIES MITIGATION PDF
(Rus)
Ibragimova G., Nasyrov R., Gaisarov A.
卷 3, 编号 6 (2015) ANALYSIS OF THE PRICING OF MEDICINAL DRUGS IN THE CURRENT ECONOMIC CLIMATE PDF
(Rus)
Bat N., Nadyrova S.
卷 2, 编号 6 (2014) ANALYSIS OF PHARMACOLOGICAL APPROACHES TO IMPROVE THE PHYSICAL HEALTH OF RESCUE WORKERS IN EMERGENCY SITUATIONS
Kupko E., Gusova B., Molchanov M., Semukhin A.
卷 3, 编号 5s (2015) ANALYSIS OF THE EFFICACY OF THE USE OF NEURALLY MEDIATED AMINOACIDS DERIVATIVES IN CONDITIONS OF ACUTE HEMIC HYPOXIA PDF
(Rus)
Makarova L., Pogorelyi V., Novikova N., Prikhodko M., Oleynikova O., Kosyanok N., Ozerov A.
卷 2, 编号 6 (2014) DEMAND ON ADSORPTIVE INTESTINAL PREPARATIONS ANALYSIS USING A VYSHKOVSKY'S INDEX PDF
(Rus)
Bondarev A., Zhilyakova E.
1 - 150 的 514 信息 1 2 3 4 > >> 

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».